198 results on '"Connors, Joseph M."'
Search Results
2. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
3. The outcome of older adults with classic Hodgkin lymphoma in British Columbia
4. Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach
5. Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines
6. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach
7. Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
8. Molecular features of a large cohort of primary central nervous system lymphoma using tissue microarray
9. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma
10. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
11. FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy
12. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
13. Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
14. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma
15. 172 - Hodgkin Lymphoma
16. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
17. Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
18. Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis
19. Cell of origin of transformed follicular lymphoma
20. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation
21. Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma
22. Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
23. An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup
24. Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma
25. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
26. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
27. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
28. Treatment and Outcomes in Patients With Primary Cutaneous B-Cell Lymphoma: The BC Cancer Agency Experience
29. Analysis of FOXO1 mutations in diffuse large B-cell lymphoma
30. Non-Hodgkin lymphoma: the clinician's perspective—a view from the receiving end
31. Treatment and Outcomes of Primary Breast Lymphoma
32. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma
33. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
34. A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
35. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
36. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project
37. Contributors
38. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
39. The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
40. Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada
41. Cooperative Epigenetic Modulation by Cancer Amplicon Genes
42. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
43. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
44. Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma
45. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP
46. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
47. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
48. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
49. Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
50. ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.